This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Minkin, R. Articles by Shapiro, J. M. Search for Related Content PubMed PubMed Citation Articles by Minkin, R. Articles by Shapiro, J. M. Social Bookmarking                   What's this?

Use of Admission Troponin in Critically Ill Medical Patients

Department of Medicine, St. Luke’s-Roosevelt Hospital Center, New York, New York, rminkin{at}chpnet.org

Delia Cotiga, MD

Department of Medicine, St. Luke’s-Roosevelt Hospital Center, New York, New York

Sigrid Noack, MD

Department of Medicine, St. Luke’s-Roosevelt Hospital Center, New York, New York

Andrei Dobrescu, MD

Department of Medicine, St. Luke’s-Roosevelt Hospital Center, New York, New York

Peter Homel, PhD

Beth Israel Medical Center, New York, New York

Janet M. Shapiro, MD

Department of Medicine, St. Luke’s-Roosevelt Hospital Center, New York, New York

Serum troponin I (TnI) is a sensitive marker of cardiac injury. A relation between elevated TnI and mortality has been suggested. In this retrospective chart review of 221 patients admitted to the medical intensive care unit (MICU) during a 6-month period, the authors studied the use of admission TnI levels in predicting mortality in MICU-admitted patients. Data retrieved included demographics, admission diagnosis, troponin, electrocardiogram, Acute Physiology and Chronic Health Evaluation (APACHE) II score, echocardiogram, requirements for mechanical ventilation and vasopressor support, development of multiorgan failure, mortality, and discharge disposition. There were 132 patients for whom TnI level was sent within 24 hours of admission; these patients comprised the study group. The median age was 70 years; 59% were female. The mean APACHE II score was 22. Troponin I was positive in 31% of patients (median level, 0.4 Ug/L; range 0-358 Ug/L). The hospital mortality was 39%. Positive TnI showed a weak association with intensive care unit (ICU) mortality (P = .049) but not with overall mortality. There was no significant correlation between admission TnI concentration and APACHE II score (P = .33), administration of vasopressor medications (P = .115), or development of multiorgan failure (P = .64). The authors concluded that there is no benefit in obtaining a routine admission troponin level in MICU patients when an acute coronary event is not suspected.

Key Words: troponin • intensive care unit • critically ill

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?